Artificial intelligence (AI) isn't the only industry with explosive growth potential.

DermCeutical EDLTM is a topical bioactive ingredient that Debut claims delivers skin-tightening benefits.

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

But deciding if it's a good buy takes a little more looking.

Genentech, a San Francisco-based biotech company, has decided to more than double its investment in a new drug manufacturing ...

A life sciences hub in Syracuse is getting a major upgrade as New York pushes to grow its biotechnology sector. Gov. Kathy ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...

Atara Biotherapeutics in Thousand Oaks is seeking approval for a new cancer treatment. It's a life and death matter for patients and the company.

Amid the expected positive clinical trial results, Legend Biotech has also reiterated plans to achieve profitability in 2026.

Brennen McKenzie, MA, MSc, VMD, director of veterinary medicine at Loyal, a biotechnology company focusing on extending the healthy lifespan of dogs, shares medications the company is developing.